• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CRO Solutions launches VxP Pharma

CRO Solutions launches VxP Pharma

July 24, 2013
CenterWatch Staff

CRO Solutions has launched VxP Pharma, a wholly-owned subsidiary. VxP Pharma offers the combined services of the independently owned and operated "niche" CROs of its parent company. VxP Pharma will offer pharmaceutical development services and technical support from discovery through phase IIb.

The majority of VxP Pharma's labs are in the U.S., although it also has facilities in Europe and Asia. All sites have been fully audited by CRO Solutions and VxP Pharma, as well as by global pharmaceutical and biotechnology clients. Most sites also have been audited by the FDA and other  regulatory agencies.

"Pharmaceutical and biotech research scientists throughout the industry tell us that they prefer to work with smaller, focused CROs, rather than with the huge multinational 'one-size-fits-all' CROs,” said Raymond E Peck, VxP Pharma chief executive officer. “For these people, VxP Pharma fits because we offer a single point of contact. Because VxP consists of smaller, independently owned and operated facilities that focus only on one area of drug development, our clients get all the advantages of working directly with a specialist ‘niche’ CRO."

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing